未登录 CUP-ONE trial: A prospective double-blind validation of molecular classifiers in the diagnosis of cancer of unknown primary and clinical outcomes Wasan, H. S.; Wang, J.; McCartney, E. M. Elaine; Soifer, H.; Treuner, K.; Zhang, Y.; Schnabel, C.; Carty, K.; McMahon, L.; Evans, T. R. J.; Nicolson, M. C.; Thygesen, H.; Roche, J. R.; Oien, K. A. 分享 收藏
Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial Fennell, Dean A.; Porter, Catharine; Lester, Jason; Danson, Sarah; Blackhall, Fiona; Nicolson, Marianne; Nixon, Lisette; Gardner, Georgina; White, Ann; Griffiths, Gareth; Casbard, Angela 分享 收藏
TGFβ2 Induces the Soluble Isoform of CTLA-4-Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma Khanolkar, Rahul C.; Zhang, Chu; Al-Fatyan, Farah; Lawson, Linda; Depasquale, Ivan; Meredith, Fiona M.; Muller, Frank; Nicolson, Marianne; Dahal, Lekh Nath; Abu-Eid, Rasha; Rajpara, Sanjay; Barker, Robert Norman; Ormerod, Anthony D.; Ward, Frank James 分享 收藏
分享 收藏
Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial Ferry, David; Billingham, Lucinda; Jarrett, Hugh; Dunlop, David; Woll, Penella J.; Nicolson, Marianne; Shah, Riyaz; Thompson, Joyce; Spicer, James; Muthukumar, D.; Skailes, Geraldine; Leonard, Pauline; Chetiyawardana, A. D.; Wells, Paula; Lewanski, Conrad; Crosse, Barbara; Hill, Michelle; Gaunt, Piers; O'Byrne, Kenneth 分享 收藏
Tracking the Evolution of Non–Small-Cell Lung Cancer 追踪非小细胞肺癌的演变 Jamal-Hanjani, M.; Wilson, G. A.; McGranahan, N.; Birkbak, N. J.; Watkins, T. B. K.; Veeriah, S.; Shafi, S.; Johnson, D. H.; Mitter, R.; Rosenthal, R.; Salm, M.; Horswell, S.; Escudero, M.; Matthews, N.; Rowan, A.; Chambers, T.; Moore, D. A.; Turajlic, S.; Xu, H.; Lee, S. -M.; Forster, M. D.; Ahmad, T.; Hiley, C. T.; Abbosh, C.; Falzon, M.; Borg, E.; Marafioti, T.; Lawrence, D.; Hayward, M.; Kolvekar, S.; Panagiotopoulos, N.; Janes, S. M.; Thakrar, R.; Ahmed, A.; Blackhall, F.; Summers, Y.; Shah, R.; Joseph, L.; Quinn, A. M.; Crosbie, P. A.; Naidu, B.; Middleton, G.; Langman, G.; Trotter, S.; Nicolson, M.; Remmen, H.; Kerr, K.; Chetty, M.; Gomersall, L.; Fennell, D. A.; Nakas, A.; Rathinam, S.; Anand, G.; Khan, S.; Russell, P.; Ezhil, V.; Ismail, B.; Irvin-Sellers, M.; Prakash, V.; Lester, J. F.; Kornaszewska, M.; Attanoos, R.; Adams, H.; Davies, H.; Dentro, S.; Taniere, P.; O'Sullivan, B.; Lowe, H. L.; Hartley, J. A.; Iles, N.; Bell, H.; Ngai, Y.; Shaw, J. A.; Herrero, J.; Szallasi, Z.; Schwarz, R. F.; Stewart, A.; Quezada, S. A.; Le Quesne, J.; Van Loo, P.; Dive, C.; Hackshaw, A.; Swanton, C. 分享 收藏
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation Cree, Ian A.; Booton, Richard; Cane, Paul; Gosney, John; Ibrahim, Merdol; Kerr, Keith; Lal, Rohit; Lewanski, Conrad; Navani, Neal; Nicholson, Andrew G.; Nicolson, Marianne; Summers, Yvonne 分享 收藏
Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK Califano, R.; Tariq, N.; Compton, S.; Fitzgerald, D. A.; Harwood, C. A.; Lal, R.; Lester, J.; McPhelim, J.; Mulatero, C.; Subramanian, S.; Thomas, A.; Thatcher, N.; Nicolson, M. 分享 收藏
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease 第二届ESMO肺癌共识会议: 非小细胞肺癌晚期疾病的一线/二线和进一步治疗 Besse, B.; Adjei, A.; Baas, P.; Meldgaard, P.; Nicolson, M.; Paz-Ares, L.; Reck, M.; Smit, E. F.; Syrigos, K.; Stahel, R.; Felip, E.; Peters, S. 分享 收藏
Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: The United Kingdom Named Patient Programme Khan, F.; Ottensmeier, C.; Popat, S.; Dua, D.; Dorey, N.; Ellis, S.; Szabo, M.; Upadhyay, S.; Califano, R.; Chan, S.; Lee, L.; Ali, C. W.; Nicolson, M.; Bates, A. T.; Button, M.; Chaudhuri, A.; Mulvenna, P.; Shaw, H. M.; Danson, S. J. 分享 收藏
Comorbidities in lung cancer: prevalence, severity and links with socioeconomic status and treatment Grose, Derek; Morrison, David S.; Devereux, Graham; Jones, Richard; Sharma, Dave; Selby, Colin; Docherty, Kirsty; McIntosh, David; Louden, Greig; Nicolson, Marianne; McMillan, Donald C.; Milroy, Robert 分享 收藏
Improving care for patients with lung cancer in the UK Sethi, Tariq; Lim, Eric; Peake, Mick; Field, John; White, John; Nicolson, Marianne; Faivre-Finn, Corinne; Cane, Paul; Reynolds, John; Moller, Henrik; Pinnock, Hilary 分享 收藏
Home administration of maintenance pemetrexed for patients with advanced non-squamous non-small cell lung cancer: rationale, practicalities and phase II feasibility study design Lal, Rohit; Bourayou, Nawel; Hillerdal, Gunnar; Nicolson, Marianne; Vikstrom, Anders; Lorenzo, Maria; D'yachkova, Yulia; Barriga, Susana; Visseren-Grul, Carla 分享 收藏
分享 收藏
Reducing the time before consulting with symptoms of Lung cancer: a randomised controlled trial in primary care Smith, Sarah; Fielding, Shona; Murchie, Peter; Johnston, Marie; Wyke, Sally; Powell, Rachael; Devereux, Graham; Nicolson, Marianne; Macleod, Una; Wilson, Phil; Ritchie, Lewis; Lee, Amanda J.; Campbell, Neil C. 分享 收藏
Developing a complex intervention to reduce time to presentation with symptoms of lung cancer Smith, Sarah M.; Murchie, Peter; Devereux, Graham; Johnston, Marie; Lee, Amanda J.; Macleod, Una; Nicolson, Marianne C.; Powell, Rachael; Ritchie, Lewis D.; Wyke, Sally; Campbell, Neil C. 分享 收藏
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study Roy, A.; Cunningham, D.; Hawkins, R.; Sorbye, H.; Adenis, A.; Barcelo, J-R; Lopez-Vivanco, G.; Adler, G.; Canon, J-L; Lofts, F.; Castanon, C.; Fonseca, E.; Rixe, O.; Aparicio, J.; Cassinello, J.; Nicolson, M.; Mousseau, M.; Schalhorn, A.; D'Hondt, L.; Kerger, J.; Hossfeld, D. K.; Giron, C. Garcia; Rodriguez, R.; Schoffski, P.; Misset, J-L 分享 收藏
QUALITY OF LIFE IN ADVANCED NON-SMALL CELL LUNG CANCER, EFFECTS OF CISPLATIN DOSE AND CARBOPLATIN IN COMBINATION WITH GEMCITABINE: RESULTS FROM BTOG2, A BRITISH THORACIC ONCOLOGY GROUP PHASE III TRIAL IN 1363 PATIENTS Billingham, L. J.; Gaunt, P.; Jarrett, H. W.; Dunlop, D.; Thompson, J.; O'Byrne, K. J.; Kumar, M.; Skailes, G.; Nicolson, M.; Shah, R.; Leonard, P.; Chetiyawardana, A.; Wells, P.; Lewanski, C.; Woll, P.; Crosse, B.; Hill, M.; Ferry, D. 分享 收藏
BRITISH THORACIC ONCOLOGY GROUP TRIAL, BTOG2: RANDOMISED PHASE III CLINICAL TRIAL OF GEMCITABINE COMBINED WITH CISPLATIN 50 MG/M2 (GC50) VS CISPLATIN 80 MG/M2 (GC80) VS CARBOPLATIN AUC 6 (GCB6) IN ADVANCED NSCLC Ferry, D.; Billingham, L. J.; Jarrett, H. W.; Dunlop, D.; Thompson, J.; Kumar, M.; Skailes, G.; Nicolson, M.; Shah, R.; Leonard, P.; Chetiyawardana, A.; Wells, P.; Lewanski, C.; Woll, P.; Crosse, B.; Hill, M.; Pirrie, S.; O'Byrne, K. J. 分享 收藏
DELIVERED DOSE INTENSITY OF GEMCITABINE 1250 MG/M2 WITH CISPLATIN AT 80 MG/M2 (GC80) AND 50 MG/M2 (GC50) AND CARBOPLATIN AUC 6 (GCB6) IN A PHASE III TRIAL OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): CORRELATIONS WITH CLINICAL OUTCOMES Dunlop, D.; Ferry, D.; Jarrett, H. W.; Billingham, L. J.; Thompson, J.; Kumar, M.; Skailes, G.; Nicolson, M.; Shah, R.; Leonard, P.; Chetiyawardana, A.; Wells, P.; Lewanski, C.; Woll, P.; Crosse, B.; O'Byrne, K. J. 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
